Table: Shin Nippon Biomedical -Q1 group results

Shin Nippon Biomedical Laboratories

05/08/2026 09:55

    Aug 5 (Reuters)- 
             Shin Nippon Biomedical Laboratories Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2026        Jun 30, 2025     Mar 31, 2027 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             7.87                6.48             38.00    
                 (+21.5 pct)         (+16.7 pct)      (+16.8 pct) 
  Operating        521 mln          loss 340 mln          3.00    
                                                      (+13.0 pct) 
  Recurring         1.43               515 mln            6.00    
                (+177.9 pct)         (+50.8 pct)      (+2.9 pct)  
  Net               1.06               260 mln            3.50    
                (+308.6 pct)        (+113.1 pct)      (-23.4 pct) 
  EPS             25.55 yen           6.25 yen         84.07 yen  
  Ann Div                             50.00 yen        50.00 yen  
  -Q2 div                             20.00 yen        20.00 yen  
  -Q4 div                             30.00 yen        30.00 yen  
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T